| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1055/S-0030-1247128 |
| P698 | PubMed publication ID | 20175029 |
| P2093 | author name string | Morris Sherman | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| hepatocellular carcinoma | Q1148337 | ||
| diagnosis | Q16644043 | ||
| P304 | page(s) | 3-16 | |
| P577 | publication date | 2010-02-19 | |
| P1433 | published in | Seminars in Liver Disease | Q15724477 |
| P1476 | title | Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis | |
| P478 | volume | 30 |
| Q35679594 | A Collision Probability Model of Portal Vein Tumor Thrombus Formation in Hepatocellular Carcinoma |
| Q40084991 | A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. |
| Q33869355 | A carbohydrate-grafted nanovesicle with activatable optical and acoustic contrasts for dual modality high performance tumor imaging |
| Q58751966 | ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin |
| Q44604444 | Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samples |
| Q36033548 | Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development |
| Q33894802 | Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injury |
| Q43909257 | Anticancer effect of ursolic acid stearoyl glucoside in chemically induced hepatocellular carcinoma |
| Q42255569 | Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal |
| Q40159677 | Assessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study |
| Q38110321 | Assessment of treatment response in hepatocellular carcinoma: a review of the literature. |
| Q45324564 | Association of ACYP2 and MPHOSPH6 genetic polymorphisms with the risk of hepatocellular carcinoma in chronic hepatitis B virus carriers |
| Q36705411 | Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection. |
| Q92528185 | Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma |
| Q91658595 | Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma |
| Q47442230 | Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma |
| Q36305413 | CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition |
| Q35992390 | Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway |
| Q46104385 | Causes of death in patients with hepatitis B: a natural history cohort study in the United States |
| Q58707841 | Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma |
| Q37094456 | Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. |
| Q46270707 | Cirrhosis and LI-RADS. |
| Q28078684 | Clinical Advancements in the Targeted Therapies against Liver Fibrosis. |
| Q47132945 | Clinical Characteristics of 130 Patients With Hepatocellular Carcinoma Followed at a Tertiary Hospital From Brazil |
| Q39970001 | Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area. |
| Q43686220 | Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program? |
| Q41054345 | Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. |
| Q91975284 | Comparative Effectiveness of Radiofrequency Ablation vs. Surgical Resection for Patients With Solitary Hepatocellular Carcinoma Smaller Than 5 cm |
| Q91828979 | Comparative Effectiveness of Radiofrequency Ablation, Surgical Resection and Transplantation for Early Hepatocellular Carcinoma by Cancer Risk Groups: Results of Propensity Score-Weighted Analysis |
| Q39097001 | Comparative bioactive studies between wild plant and callus culture of Tephrosia tinctoria pers |
| Q37719989 | Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma |
| Q37580211 | Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth |
| Q39427956 | Construction and characterization of an anti-asialoglycoprotein receptor single-chain variable-fragment-targeted melittin. |
| Q43047082 | Controversies in surveillance and early diagnosis of hepatocellular carcinoma. |
| Q64959827 | Current issues on genomic heterogeneity in hepatocellular carcinoma and its implication in clinical practice. |
| Q49334369 | Current state and clinical outcome in Turkish patients with hepatocellular carcinoma |
| Q44365341 | DEN+2-AAF-induced multistep hepatotumorigenesis in Wistar rats: supportive evidence and insights |
| Q58011404 | Das hepatozelluläre Karzinom |
| Q35850889 | Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients |
| Q38408866 | Diagnosis and treatment of hepatocellular carcinoma: An update |
| Q57972656 | Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma |
| Q47366717 | Diagnostic value of strand‐specific miRNA‐101‐3p and miRNA‐101‐5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action |
| Q55241142 | Different Sex-Based Responses of Gut Microbiota During the Development of Hepatocellular Carcinoma in Liver-Specific Tsc1-Knockout Mice. |
| Q36783264 | Different faces of hepatocellular carcinoma as a health threat in 21st century |
| Q57569019 | Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma |
| Q31119452 | Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model |
| Q87382791 | Early diagnosis of hepatocellular carcinoma by microRNAs: shining a light from the genome's "dark matter" |
| Q93384272 | Effectiveness of Particle Radiotherapy in Various Stages of Hepatocellular Carcinoma: A Pilot Study |
| Q36153175 | Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma |
| Q38761242 | Effects of shRNA-Mediated SOX9 Inhibition on Cell Proliferation and Apoptosis in Human HCC Cell Line Hep3B Mediated by Ultrasound-Targeted Microbubble Destruction (UTMD). |
| Q62489408 | Efficacy of Hepatic Resection vs. Radiofrequency Ablation for Patients With Very-Early-Stage or Early-Stage Hepatocellular Carcinoma: A Population-Based Study With Stratification by Age and Tumor Size |
| Q38630530 | Evaluating the current surgical strategies for hepatocellular carcinoma |
| Q38265024 | Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment. |
| Q57073368 | Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus‑positive cirrhosis |
| Q37363773 | Experimental liver fibrosis research: update on animal models, legal issues and translational aspects |
| Q36590103 | Expression of partitioning defective 3 (Par-3) for predicting extrahepatic metastasis and survival with hepatocellular carcinoma |
| Q36016036 | Family history influences the early onset of hepatocellular carcinoma |
| Q35231830 | Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma. |
| Q39262323 | Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis |
| Q33900599 | Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinoma. |
| Q42232294 | GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma. |
| Q34675546 | Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles |
| Q35159505 | Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis. |
| Q28483934 | Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma |
| Q92651188 | HBV Integration-mediated Cell Apoptosis in HepG2.2.15 |
| Q30245486 | HIV, Aging, and Viral Coinfections: Taking the Long View. |
| Q37613675 | Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India |
| Q45325992 | Hepatitis B Virus-Associated Hepatocellular Carcinoma |
| Q41955691 | Hepatitis B virus and host factors |
| Q33874864 | Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort study. |
| Q35728873 | Hepatitis C virus infection: establishment of chronicity and liver disease progression |
| Q26738545 | Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms |
| Q29616359 | Hepatocellular carcinoma |
| Q37429037 | Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report |
| Q37403255 | Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. |
| Q40268349 | Hepatocellular carcinoma in Danish patients: a single Copenhagen center experience |
| Q57911034 | Hepatocellular carcinoma in a North American population: Does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? |
| Q35668716 | Hepatocellular carcinoma: From diagnosis to treatment |
| Q37813192 | Hepatocellular carcinoma: diagnostics and screening |
| Q33820846 | High expression of polo-like kinase 1 is associated with early development of hepatocellular carcinoma |
| Q59353478 | High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection |
| Q34103576 | Histological classification of liver and intrahepatic bile duct cancers in SEER registries. |
| Q26750792 | Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma |
| Q35762937 | Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9 |
| Q35611332 | Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma |
| Q40044138 | Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma |
| Q51027268 | Immunoexpression of Heat Shock Protein 70, Glypican 3, Glutamine Synthetase, and Beta-Catenin in Hepatocellular Carcinoma After Liver Transplantation: Association Between Positive Glypican 3 and Beta-Catenin With the Presence of Larger Nodules. |
| Q49648449 | Immunohistochemical and Biochemical Expression Patterns of TTF-1, RAGE, GLUT-1 and SOX2 in HCV-Associated Hepatocellular Carcinomas |
| Q91722558 | In vivo ultrasound thermal ablation control using echo decorrelation imaging in rabbit liver and VX2 tumor |
| Q50050604 | Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis |
| Q35679527 | Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma. |
| Q34483623 | Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma |
| Q36393694 | Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73. |
| Q41054340 | Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation |
| Q38162294 | Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age? |
| Q33721561 | Leptomeningeal metastasis from hepatocellular carcinoma with other unusual metastases: a case report |
| Q37860680 | Liver precancerous lesions and hepatocellular carcinoma: the histology report. |
| Q88979476 | Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure? |
| Q90364036 | LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7 |
| Q92220681 | Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells |
| Q54711319 | Long-term outcome of laparoscopic versus open liver resection for hepatocellular carcinoma: a case-controlled study with propensity score matching. |
| Q38170197 | Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review |
| Q36952452 | Low fat intake is associated with pathological manifestations and poor recovery in patients with hepatocellular carcinoma. |
| Q36145296 | Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection |
| Q27005624 | Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound |
| Q42145532 | MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma |
| Q52649693 | MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study. |
| Q91639498 | MicroRNA-132-3p regulates cell proliferation, apoptosis, migration and invasion of liver cancer by targeting Sox4 |
| Q37407115 | Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors |
| Q42610253 | Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation. |
| Q38212573 | Molecular targeted therapy in hepatocellular carcinoma: from biology to clinical practice and future |
| Q37920769 | Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review |
| Q42200065 | Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma? |
| Q33814414 | NCOA5, a molecular link between type 2 diabetes and liver cancer |
| Q34308762 | No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. |
| Q36229496 | Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B. |
| Q38874797 | Osthole promotes anti-tumor immune responses in tumor-bearing mice with hepatocellular carcinoma |
| Q55478019 | Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis. |
| Q32179190 | Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma |
| Q39509223 | Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma |
| Q37491353 | Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy |
| Q39212821 | Potential ultrastructure predicting factors for hepatocellular carcinoma in HCV infected patients |
| Q38773506 | Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma |
| Q39419229 | Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials |
| Q42256081 | Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India |
| Q43544108 | Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma |
| Q35198372 | Progression from cirrhosis to cancer is associated with early ubiquitin post-translational modifications: identification of new biomarkers of cirrhosis at risk of malignancy |
| Q35140999 | RETRACTED: Growth inhibition and apoptosis induced by 6-fluoro-3-formylchromone in hepatocellular carcinoma |
| Q27027683 | Radiological diagnosis of hepatocellular carcinoma |
| Q39150740 | Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway |
| Q30460837 | Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma |
| Q35612709 | Recognizing and preventing death from compensated cirrhosis in the community |
| Q38986144 | Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis |
| Q42378708 | Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma |
| Q35668724 | Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues |
| Q35102439 | Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies |
| Q84242422 | Role of operative therapy in non-cirrhotic patients with metastatic hepatocellular carcinoma |
| Q37957971 | Role of stress-induced NKG2D ligands in liver diseases. |
| Q37989160 | Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma |
| Q43105330 | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. |
| Q59330366 | Safranal induces DNA double-strand breakage and ER-stress-mediated cell death in hepatocellular carcinoma cells |
| Q30244651 | Screening and surveillance for hepatocellular carcinoma: perspective of a new era? |
| Q38971537 | Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure |
| Q37516483 | Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays |
| Q36294432 | Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma |
| Q41534186 | Serum fibronectin distinguishes the early stages of hepatocellular carcinoma |
| Q36759142 | Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection |
| Q39015625 | Should we routinely use DEBTACE for unresectable HCC? cTACE versus DEBTACE: a single-center survival analysis. |
| Q35405060 | Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model |
| Q37138421 | Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients |
| Q34425031 | Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma |
| Q38207014 | Staging systems of hepatocellular carcinoma: a review of literature |
| Q61799108 | Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients |
| Q64060157 | Strategies to Circumvent Host Innate Immune Response by Hepatitis C Virus |
| Q54485235 | Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib. |
| Q90235453 | Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness? |
| Q37564545 | Systematic analyses and comprehensive field synopsis of genetic association studies in hepatocellular carcinoma |
| Q37734673 | Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133. |
| Q39529070 | TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?. |
| Q39458547 | Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies. |
| Q28546913 | The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes |
| Q42053662 | The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway |
| Q41736718 | The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma |
| Q89716537 | The risk of complications of endoscopic procedures in patients with liver cirrhosis |
| Q42201891 | The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area |
| Q38917897 | Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages. |
| Q38371630 | Tissue diagnosis of hepatocellular carcinoma |
| Q33919629 | Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study. |
| Q35809215 | Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC) |
| Q55248001 | Transforming growth factor-β1 and lysophosphatidic acid activate integrin β6 gene promoter in Hep-3B cells. |
| Q38008950 | Translational medicine in hepatocellular carcinoma |
| Q36430416 | Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report |
| Q100529084 | Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma |
| Q57116779 | Two Nomograms to Select Hepatocellular Carcinoma Patients with Macroscopic Vascular Invasion for Hepatic Resection |
| Q90398674 | UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma |
| Q58415981 | Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities |
| Q36718770 | Upper midline incision for liver resection |
| Q35943256 | Wogonoside induces apoptosis in Bel-7402, a hepatocellular carcinoma cell line, by regulating Bax/Bcl-2. |
| Q94452973 | microRNA-519d Induces Autophagy and Apoptosis of Human Hepatocellular Carcinoma Cells Through Activation of the AMPK Signaling Pathway via Rab10 |
Search more.